Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ICJ
|
||||
Former ID |
DNC010619
|
||||
Drug Name |
4-benzhydryl-N-cyclohexylpiperazine-1-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530617] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H31N3O
|
||||
Canonical SMILES |
C1CCC(CC1)NC(=O)N2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4
|
||||
InChI |
1S/C24H31N3O/c28-24(25-22-14-8-3-9-15-22)27-18-16-26(17-19-27)23(20-10-4-1-5-11-20)21-12-6-2-7-13-21/h1-2,4-7,10-13,22-23H,3,8-9,14-19H2,(H,25,28)
|
||||
InChIKey |
IRRGBCHOFRYUCB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Inhibitor | [530617] | |
Cannabinoid receptor 1 | Target Info | Inhibitor | [530617] | ||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.